Follow
Robert Steinbach
Robert Steinbach
Universitätsklinik für Neurologie Jena
Verified email at med.uni-jena.de
Title
Cited by
Cited by
Year
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ...
Nature genetics 53 (12), 1636-1648, 2021
2912021
Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis
S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ...
JAMA neurology 79 (2), 121-130, 2022
1082022
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
E Jochmann, R Steinbach, T Jochmann, HY Chung, A Rödiger, ...
Therapeutic advances in neurological disorders 13, 1756286420907803, 2020
402020
Cerebrospinal fluid neurofilament light chain (NFL) predicts disease aggressiveness in amyotrophic lateral sclerosis: an application of the D50 disease progression model
M Dreger, R Steinbach, N Gaur, K Metzner, B Stubendorff, OW Witte, ...
Frontiers in neuroscience 15, 651651, 2021
282021
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
A Pechmann, M Behrens, K Dörnbrack, A Tassoni, S Stein, S Vogt, ...
Brain 146 (2), 668-677, 2023
252023
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
M Dreger, R Steinbach, M Otto, MR Turner, J Grosskreutz
Journal of Neurology, Neurosurgery & Psychiatry 93 (4), 422-435, 2022
252022
Structural hallmarks of amyotrophic lateral sclerosis progression revealed by probabilistic fiber tractography
R Steinbach, K Loewe, J Kaufmann, J Machts, K Kollewe, S Petri, ...
Journal of neurology 262, 2257-2270, 2015
242015
Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
R Steinbach, M Batyrbekova, N Gaur, A Voss, B Stubendorff, TE Mayer, ...
NeuroImage: Clinical 25, 102094, 2020
222020
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
T Meyer, A Maier, Z Uzelac, T Hagenacker, R Günther, O Schreiber‐Katz, ...
European Journal of Neurology 28 (8), 2582-2595, 2021
212021
Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
J Thome, R Steinbach, J Grosskreutz, D Durstewitz, G Koppe
Human brain mapping 43 (2), 681-699, 2022
192022
Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
R Steinbach, N Gaur, A Roediger, TE Mayer, OW Witte, T Prell, ...
Human Brain Mapping 42 (3), 737-752, 2021
182021
Symptomatic pharmacotherapy in ALS: Data analysis from a platform-based medication management programme
T Meyer, D Kettemann, A Maier, T Grehl, U Weyen, J Grosskreutz, ...
Journal of Neurology, Neurosurgery & Psychiatry 91 (7), 783-785, 2020
182020
Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
T Prell, N Gaur, R Steinbach, OW Witte, J Grosskreutz
Health and Quality of Life Outcomes 18, 1-5, 2020
162020
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale–a multicenter observational study
T Meyer, S Spittel, T Grehl, U Weyen, R Steinbach, D Kettemann, S Petri, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (3-4), 175-184, 2023
142023
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy
DC Schorling, H Kölbel, A Hentschel, A Pechmann, N Meyer, B Wirth, ...
European Journal of Neurology 29 (7), 2084-2096, 2022
132022
Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
R Steinbach, T Prell, N Gaur, A Roediger, C Gaser, TE Mayer, OW Witte, ...
NeuroImage: Clinical 30, 102674, 2021
132021
Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
N Dieckmann, A Roediger, T Prell, S Schuster, M Herdick, TE Mayer, ...
NeuroImage: Clinical 36, 103162, 2022
112022
Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-center data sharing and the road to a “Global Cohort”
R Steinbach, N Gaur, B Stubendorff, OW Witte, J Grosskreutz
Frontiers in Neurology 9, 1055, 2018
112018
Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
R Steinbach, T Prell, N Gaur, B Stubendorff, A Roediger, B Ilse, OW Witte, ...
Journal of clinical medicine 9 (9), 2873, 2020
102020
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations
M Wiesenfarth, K Günther, K Müller, S Witzel, U Weiland, K Mayer, ...
Brain Communications 5 (2), fcad087, 2023
92023
The system can't perform the operation now. Try again later.
Articles 1–20